Provided by Tiger Trade Technology Pte. Ltd.

Argenx SE

1,039.78
+1.660.16%
Post-market: 1,041.251.47+0.14%19:58 EDT
Volume:377.30K
Turnover:394.27M
Market Cap:65.03B
PE:39.67
High:1,058.69
Open:1,034.98
Low:1,029.46
Close:1,038.12
52wk High:1,058.69
52wk Low:658.60
Shares:62.54M
Float Shares:62.45M
Volume Ratio:0.97
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):26.21
EPS(LYR):19.57
ROE:23.63%
ROA:11.63%
PB:7.73
PE(LYR):53.13

Loading ...

Argenx rises 14.9%

TIPRANKS
·
Aug 17

Movement Alert|Argenx SE Rises 9.45% in Regular Trading, Phase 3 Trial of Efgartigimod in Autoimmune Myositis Meets Primary Endpoint

Market Focus
·
Aug 17

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday Amid Lower Rate Hike Expectations

MT Newswires Live
·
Aug 17

Sector Update: Healthcare

MT Newswires Live
·
Aug 17

Argenx price target raised to $1,215 from $1,075 at Piper Sandler

TIPRANKS
·
Aug 17

Movement Alert|Argenx SE Rises 5% in Pre-Market Trading, Phase 3 Trial of Efgartigimod in Autoimmune Myositis Meets Primary Endpoint

Market Focus
·
Aug 17

argenx Says Autoimmune Myositis Drug Meets Main Goal in Phase 3 Study

MT Newswires Live
·
Aug 17

Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod

Dow Jones
·
Aug 17

European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading

MT Newswires Live
·
Aug 14

Argenx Advances Empasiprubart in Rare Nerve Disorder, Adding Long-Term Upside for ARGX Investors

TIPRANKS
·
Aug 14

Argenx resumed with a Buy at Guggenheim

TIPRANKS
·
Aug 05

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Aug 03

European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading

MT Newswires Live
·
Jul 30

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Argenx Se (ARGX)

TIPRANKS
·
Jul 29

Argenx is Maintained at Outperform by Wedbush

Dow Jones
·
Jul 28

Argenx price target raised to $1,050 from $1,000 at Wedbush

TIPRANKS
·
Jul 28

Argenx Se : Wedbush Raises Target Price to $1050 from $1000

THOMSON REUTERS
·
Jul 28

Forte Biosciences downgraded to Equal Weight from Overweight at Barclays

TIPRANKS
·
Jul 28

Argenx's Forte Bio Deal Validates CEO Change

Dow Jones
·
Jul 28

Movement Alert|Argenx SE Falls 3.01% in Regular Trading, $2.2 Billion Cash Acquisition of Forte Biosciences Triggers Market Digestion

Market Focus
·
Jul 28